BlackRock Fund Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6.84M Buy
1,415,270
+158,128
+13% +$4.69M ﹤0.01% 2781
2016
Q3
$58M Buy
1,257,142
+68,174
+6% +$3.84M 0.01% 1473
2016
Q2
$60.7M Buy
1,188,968
+166,961
+16% +$8.3M 0.01% 1365
2016
Q1
$43.2M Buy
1,022,007
+34,905
+4% +$1.78M 0.01% 1543
2015
Q4
$77.5M Sell
987,102
-68,540
-6% -$3.96M 0.02% 1163
2015
Q3
$42.8M Buy
1,055,642
+47,019
+5% +$2.49M 0.01% 1520
2015
Q2
$52.5M Buy
1,008,623
+234,823
+30% +$11.7M 0.01% 1490
2015
Q1
$36M Buy
773,800
+28,935
+4% +$1.5M 0.01% 1731
2014
Q4
$33.4M Buy
744,865
+445,368
+149% +$18.7M 0.01% 1748
2014
Q3
$11.7M Sell
299,497
-6,547
-2% -$257K ﹤0.01% 2258
2014
Q2
$12.9M Buy
306,044
+70,808
+30% +$2.6M ﹤0.01% 2257
2014
Q1
$8.39M Buy
235,236
+16,196
+7% +$546K ﹤0.01% 2501
2013
Q4
$7.09M Buy
+219,040
New +$6.5M ﹤0.01% 2583

Other funds holding ISEE

BlackRock Fund Advisors's ISEE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 13% in Q4 2016, buying an estimated $4.69M and bringing the position to 1,415,270 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2781.

BlackRock Fund Advisors first reported a position in ISEE in Q4 2013 and has held it in 13 quarters since. The position peaked at $77.5M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • BlackRock Fund Advisors held 1,415,270 shares of IVERIC bio, Inc. Common Stock worth $6.84M as of Q4 2016.
  • BlackRock Fund Advisors bought 158,128 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $4.69M.
  • IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2781 holding.
  • BlackRock Fund Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Fund Advisors's IVERIC bio, Inc. Common Stock position peaked at $77.5M in Q4 2015.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.